LifeMD, Inc. LFMD Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 86.1%+1.2pp | 85%+0.8pp | 84.1%-0.8pp | 84.9%-0.4pp | 85.2%-1.7pp | |
| Operating margin | -9.8%-4.3pp | -5.4%-0.1pp | -5.3%+1.4pp | -6.7%+4.2pp | -10.9%+3.7pp | |
| Net margin | 3.1%-4.8pp | 7.9%+13.8pp | -5.9%+0.7pp | -6.6%+3.8pp | -10.4%+4.7pp | |
| Efficiency | ||||||
| Asset turnover | 2.5×0.0× | 2.5×-0.1× | 2.6×+0.1× | 2.5×+0.1× | 2.4×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1×-0.2× | 1.2×+0.5× | 0.7×0.0× | 0.8×0.0× | 0.8×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×+0.1× | 0.3×-4.7× | 5×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $0.32-38.1% | $0.51+1,700% | $0.03+171% | -$0.04+25.7% | -$0.05+75.5% | |
| Valuation | ||||||
| Market capitalization | $235.53M-61.7% | $164.14M-49.0% | $321.96M-49.6% | $638.54M+163% | $242.54M+13.1% | |
| Price / earnings | 41.6×— | 11.4×— | —— | —— | —— | |
| Price / sales | 1.3×-2.3× | 0.9×-0.9× | 1.8×-1.9× | 3.7×+2.2× | 1.5×+0.1× | |
| Price / book | 15.7×— | 7.1×-238× | 245×— | —— | —— | |
| Dividend yield | 1.3%+0.8pp | 1.9%+0.9pp | 1%+0.5pp | 0.5%-0.8pp | 1.3%-0.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are LifeMD, Inc.'s profit margins?
- LifeMD, Inc. (LFMD) runs a 86.1% gross margin and a -9.8% operating margin, with a 3.1% net margin.
- Where do LifeMD, Inc.'s ratios come from?
- Every ratio is computed from LifeMD, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
